Current Allergy and Asthma Reports

, Volume 13, Issue 5, pp 434–442 | Cite as

Obesity in Asthma: Approaches to Treatment

  • Shyamala Pradeepan
  • Garth Garrison
  • Anne E. Dixon


There is mounting evidence that obesity is associated with asthma, both of which are seeing a dramatic increase in prevalence. Not only is obesity a risk factor for the development of asthma but it is also associated with poor asthma control. Asthma phenotypes associated with obesity include early-onset allergic asthma and late-onset non-allergic asthma. The pathogenesis of the linkage is complex; obesity causes a variety of mechanical, metabolic, and immunological changes that can affect the airways. The treatment of asthma in obesity can be challenging, as obesity is associated with poor response to standard controller medications. A tailored approach that involves combining pharmacologic and non-pharmacologic therapies including weight loss, dietary interventions, and exercise, along with identification and treatment of obstructive sleep apnea, should therefore be considered in this population.


Asthma Obesity Lung function Inhaled corticosteroids Leukotrienes Gastro-esophageal reflux disease GERD Obstructive sleep apnea Treatment Weight loss Exercise Comorbidities 



Anne E. Dixon has received grant support from the National Institutes of Health.

Conflict of Interest

Anne E. Dixon has served as a consultant for Boehringer Ingelheim.

Shyamala Pradeepan and Garth Garrison declare that they have no conflict of interest.


Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. 1.
    Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.PubMedCrossRefGoogle Scholar
  2. 2.
    Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175(7):661–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Taylor B, Mannino D, Brown C, Crocker D, Twum-Baah N, Holguin F. Body mass index and asthma severity in the National Asthma Survey. Thorax. 2008;63(1):14–20.PubMedCrossRefGoogle Scholar
  4. 4.
    Vortmann M, Eisner MD. BMI and health status among adults with asthma. Obesity (Silver Spring), Md. 2008;16(1):146–52.CrossRefGoogle Scholar
  5. 5.
    Mosen DM, Schatz M, Magid DJ, Camargo Jr CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol. 2008;122(3):507–11. e6.PubMedCrossRefGoogle Scholar
  6. 6.
    Salome CM, Munoz PA, Berend N, Thorpe CW, Schachter LM, King GG. Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. International journal of obesity (2005). 2008;32(3):502–9.Google Scholar
  7. 7.
    Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration. J Clin Invest. 1995;96(5):2393–403.PubMedCrossRefGoogle Scholar
  8. 8.
    Ding DJ, Martin JG, Macklem PT. Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans. JApplPhysiol. 1987 3/1987;62(3):1324–30.Google Scholar
  9. 9.
    Fredberg JJ. Frozen objects: small airways, big breaths, and asthma. JAllergy ClinImmunol. 2000 10/2000;106(4):615–24.Google Scholar
  10. 10.
    Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911–9. quiz 20.PubMedCrossRefGoogle Scholar
  11. 11.
    Shore SA, Schwartzman IN, Mellema MS, Flynt L, Imrich A, Johnston RA. Effect of leptin on allergic airway responses in mice. JAllergy ClinImmunol. 2005 1/2005;115(1):103–9.Google Scholar
  12. 12.
    Sideleva O, Suratt BT, Black KE, Tharp WG, Pratley RE, Forgione P, et al. Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med. 2012;186(7):598–605.PubMedCrossRefGoogle Scholar
  13. 13.
    Kirwin SM, Bhandari V, Dimatteo D, Barone C, Johnson L, Paul S, et al. Leptin enhances lung maturity in the fetal rat. Pediatr Res. 2006;60(2):200–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Budinger GRS, Jain M, Bellmeyer A, Urich D, Soberabes BS, Rivera SE, et al. Leptin resistance protects against fibroproliferative ARDS via loss of augmentation of TGFβ1 and preservation of PPARγ activity. Am ThoracSoc Abstr Book. 2010;181:A3771.Google Scholar
  15. 15.
    Jain M, Budinger GR, Lo A, Urich D, Rivera SE, Ghosh AK, et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-gamma. Am J Respir Crit Care Med. 2011;183(11):1490–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Shore SA, Terry RD, Flynt L, Xu A, Hug C. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. J Allergy Clin Immunol. 2006;118(2):389–95.PubMedCrossRefGoogle Scholar
  17. 17.
    Williams AS, Chen L, Kasahara DI, Si H, Wurmbrand AP, Shore SA. Obesity and airway responsiveness: Role of TNFR2. Pulm Pharmacol Ther. 2012.Google Scholar
  18. 18.
    Mathis D, Shoelson SE. Immunometabolism: an emerging frontier. Nat Rev Immunol. 2011;11(2):81.PubMedCrossRefGoogle Scholar
  19. 19.
    Lugogo NL, Hollingsworth JW, Howell DL, Que LG, Francisco D, Church TD, et al. Alveolar macrophages from overweight/obese asthmatic subjects demonstrate a pro-inflammatory phenotype. Am. J. Respir. Crit. Care Med. 2012.Google Scholar
  20. 20.
    Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. AmJPhysiol Lung Cell MolPhysiol. 2004 10/2004;287(3):L497-L502.Google Scholar
  21. 21.
    Rathmell JC. Metabolism and autophagy in the immune system: immunometabolism comes of age. Immunol Rev. 2012;249(1):5–13.PubMedCrossRefGoogle Scholar
  22. 22.
    Dixon AE, Pratley RE, Forgione PM, Kaminsky DA, Whittaker-Leclair LA, Griffes LA, et al. Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol. 2011;128(3):508–15. e1-2.PubMedCrossRefGoogle Scholar
  23. 23.
    de Vries A, Hazlewood L, Fitch PM, Seckl JR, Foster P, Howie SE. High-fat feeding redirects cytokine responses and decreases allergic airway eosinophilia. Clin Exp Allergy. 2009;39(5):731–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Holguin F, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Erzurum SC, et al. Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol. 2011;127(6):1486–93. e2.PubMedCrossRefGoogle Scholar
  25. 25.
    Sutherland ER, Goleva E, King TS, Lehman E, Stevens AD, Jackson LP, et al. Cluster analysis of obesity and asthma phenotypes. PLoS One. 2012;7(5):e36631.PubMedCrossRefGoogle Scholar
  26. 26.
    Anderson WJ, Lipworth BJ. Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma? Ann Allergy Asthma Immunol. 2012;108(4):237–42.PubMedCrossRefGoogle Scholar
  27. 27.
    Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med. 2007;101(11):2240–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Camargo Jr CA, Boulet LP, Sutherland ER, Busse WW, Yancey SW, Emmett AH, et al. Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J Asthma. 2010;47(1):76–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Camargo Jr CA, Sutherland ER, Bailey W, Castro M, Yancey SW, Emmett AH, et al. Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans. Curr Med Res Opin. 2010;26(7):1629–35.PubMedCrossRefGoogle Scholar
  30. 30.
    Forno E, Lescher R, Strunk R, Weiss S, Fuhlbrigge A, Celedon JC. Decreased response to inhaled steroids in overweight and obese asthmatic children. J Allergy Clin Immunol. 2011;127(3):741–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006;27(3):495–503.PubMedCrossRefGoogle Scholar
  32. 32.
    Sutherland ER, Camargo Jr CA, Busse WW, Meltzer EO, Ortega HG, Yancey SW, et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy Asthma Proc. 2010;31(1):20–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Sutherland ER, Lehman EB, Teodorescu M, Wechsler ME. Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol. 2009;123(6):1328–34. e1.PubMedCrossRefGoogle Scholar
  34. 34.
    Telenga ED, Tideman SW, Kerstjens HA, Hacken NH, Timens W, Postma DS, et al. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy. 2012;67(8):1060–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Yeh KH, Skowronski ME, Coreno AJ, Seitz RE, Villalba KD, Dickey-White H, et al. Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma. J Asthma. 2011;48(6):546–52.PubMedCrossRefGoogle Scholar
  36. 36.
    Stream AR, Sutherland ER. Obesity and asthma disease phenotypes. Curr Opin Allergy Clin Immunol. 2012;12(1):76–81.PubMedCrossRefGoogle Scholar
  37. 37.
    Sutherland ER, Goleva E, Strand M, Beuther DA, Leung DY. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med. 2008;178(7):682–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Boulet LP, Turcotte H, Martin J, Poirier P. Effect of bariatric surgery on airway response and lung function in obese subjects with asthma. Respir Med. 2012Google Scholar
  39. 39.
    Maniscalco M, Zedda A, Faraone S, Cerbone MR, Cristiano S, Giardiello C, et al. Weight loss and asthma control in severely obese asthmatic females. Respir Med. 2008;102(1):102–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Adeniyi FB, Young T. Weight loss interventions for chronic asthma. Cochrane Database Syst Rev. 2012;7, CD009339.PubMedGoogle Scholar
  41. 41.
    Stenius-Aarniala B, Poussa T, Kvarnstrom J, Gronlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ. 2000;320(7238):827–32.PubMedCrossRefGoogle Scholar
  42. 42.
    Scott HA, Gibson PG, Garg ML, Pretto JJ, Morgan PJ, Callister R, et al. Dietary restriction and exercise improve airway inflammation and clinical outcomes in overweight and obese asthma: a randomized trial. Clin Exp Allergy. 2012;43(1):36–49.CrossRefGoogle Scholar
  43. 43.
    Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14(4):902–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Dandona P, Ghanim H, Chaudhuri A, Dhindsa S, Kim SS. Macronutrient intake induces oxidative and inflammatory stress: potential relevance to atherosclerosis and insulin resistance. Exp Mol Med. 2010;42(4):245–53.PubMedCrossRefGoogle Scholar
  45. 45.
    Kazaks AG, Uriu-Adams JY, Albertson TE, Shenoy SF, Stern JS. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma. 2010;47(1):83–92.PubMedCrossRefGoogle Scholar
  46. 46.
    Tecklenburg SL, Mickleborough TD, Fly AD, Bai Y, Stager JM. Ascorbic acid supplementation attenuates exercise-induced bronchoconstriction in patients with asthma. Respir Med. 2007;101(8):1770–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Shaheen SO, Newson RB, Rayman MP, Wong AP, Tumilty MK, Phillips JM, et al. Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax. 2007;62(6):483–90.PubMedCrossRefGoogle Scholar
  48. 48.
    Pearson PJ, Lewis SA, Britton J, Fogarty A. Vitamin E supplements in asthma: a parallel group randomised placebo controlled trial. Thorax. 2004;59(8):652–6.PubMedCrossRefGoogle Scholar
  49. 49.
    Allan K, Devereux G. Diet and asthma: nutrition implications from prevention to treatment. J Am Diet Assoc. 2011;111(2):258–68.PubMedCrossRefGoogle Scholar
  50. 50.
    Paul G, Brehm JM, Alcorn JF, Holguin F, Aujla SJ, Celedon JC. Vitamin D and asthma. Am J Respir Crit Care Med. 2012;185(2):124–32.PubMedCrossRefGoogle Scholar
  51. 51.
    •• Wood LG, Garg ML, Gibson PG. A high-fat challenge increases airway inflammation and impairs bronchodilator recovery in asthma. J Allergy Clin Immunol. 2011;127(5):1133–40. Important study showing that a high fat diet increased airway neutrophilia and ecreased bronchodilator responsiveness in normal weight patients with asthma.PubMedCrossRefGoogle Scholar
  52. 52.
    Li J, Xun P, Zamora D, Sood A, Liu K, Daviglus M, et al. Intakes of long-chain omega-3 (n-3) PUFAs and fish in relation to incidence of asthma among American young adults: the CARDIA study. Am J Clin Nutr. 2013;97(1):173–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Schubert R, Kitz R, Beermann C, Rose MA, Lieb A, Sommerer PC, et al. Effect of n-3 polyunsaturated fatty acids in asthma after low-dose allergen challenge. Int Arch Allergy Immunol. 2009;148(4):321–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006;129(1):39–49.PubMedCrossRefGoogle Scholar
  55. 55.
    Covar R, Gleason M, Macomber B, Stewart L, Szefler P, Engelhardt K, et al. Impact of a novel nutritional formula on asthma control and biomarkers of allergic airway inflammation in children. Clin Exp Allergy. 2010;40(8):1163–74.PubMedCrossRefGoogle Scholar
  56. 56.
    Hodge L, Salome CM, Hughes JM, Liu-Brennan D, Rimmer J, Allman M, et al. Effect of dietary intake of omega-3 and omega-6 fatty acids on severity of asthma in children. Eur Respir J. 1998;11(2):361–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Sexton P, Black P, Metcalf P, Wall CR, Ley S, Wu L, et al. Influence of mediterranean diet on asthma symptoms, lung function, and systemic inflammation: a randomized controlled trial. J Asthma. 2013;50(1):75–81.PubMedCrossRefGoogle Scholar
  58. 58.
    Grigoropoulou D, Priftis KN, Yannakoulia M, Papadimitriou A, Anthracopoulos MB, Yfanti K, et al. Urban environment adherence to the Mediterranean diet and prevalence of asthma symptoms among 10- to 12-year-old children: The Physical Activity, Nutrition, and Allergies in Children Examined in Athens study. Allergy Asthma Proc. 2011;32(5):351–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Gonzalez Barcala FJ, Pertega S, Bamonde L, Garnelo L, Perez Castro T, Sampedro M, et al. Mediterranean diet and asthma in Spanish schoolchildren. Pediatr Allergy Immunol. 2010;21(7):1021–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Romieu I, Barraza-Villarreal A, Escamilla-Nunez C, Texcalac-Sangrador JL, Hernandez-Cadena L, Diaz-Sanchez D, et al. Dietary intake, lung function and airway inflammation in Mexico City school children exposed to air pollutants. Respir Res. 2009;10:122.PubMedCrossRefGoogle Scholar
  61. 61.
    Protudjer JL, Sevenhuysen GP, Ramsey CD, Kozyrskyj AL, Becker AB. Low vegetable intake is associated with allergic asthma and moderate-to-severe airway hyperresponsiveness. Pediatr Pulmonol. 2012;47(12):11.CrossRefGoogle Scholar
  62. 62.
    Uddenfeldt M, Janson C, Lampa E, Leander M, Norback D, Larsson L, et al. High BMI is related to higher incidence of asthma, while a fish and fruit diet is related to a lower- Results from a long-term follow-up study of three age groups in Sweden. Respir Med. 2010;104(7):972–80.PubMedCrossRefGoogle Scholar
  63. 63.
    •• Wood LG, Garg ML, Smart JM, Scott HA, Barker D, Gibson PG. Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr. 2012;96(3):534–43. Randomized controlled trial showing that increasing anti-oxidant intake with whole foods decreased risk of asthma exacerbations.PubMedCrossRefGoogle Scholar
  64. 64.
    Hewitt M, Creel A, Estell K, Davis IC, Schwiebert LM. Acute exercise decreases airway inflammation, but not responsiveness, in an allergic asthma model. Am J Respir Cell Mol Biol. 2009;40(1):83–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Hewitt M, Estell K, Davis IC, Schwiebert LM. Repeated bouts of moderate-intensity aerobic exercise reduce airway reactivity in a murine asthma model. Am J Respir Cell Mol Biol. 2010;42(2):243–9.PubMedCrossRefGoogle Scholar
  66. 66.
    Pastva A, Estell K, Schoeb TR, Atkinson TP, Schwiebert LM. Aerobic exercise attenuates airway inflammatory responses in a mouse model of atopic asthma. J Immunol. 2004;172(7):4520–6.PubMedGoogle Scholar
  67. 67.
    Lowder T, Dugger K, Deshane J, Estell K, Schwiebert LM. Repeated bouts of aerobic exercise enhance regulatory T cell responses in a murine asthma model. Brain Behav Immun. 2010;24(1):153–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Schan CA, Harding SM, Haile JM, Bradley LA, Richter JE. Gastroesophageal reflux-induced bronchoconstriction. An intraesophageal acid infusion study using state-of-the-art technology. Chest. 1994;106(3):731–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Harding SM. Gastroesophageal reflux and asthma: insight into the association. J Allergy Clin Immunol. 1999;104(2 Pt 1):251–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360(15):1487–99.PubMedCrossRefGoogle Scholar
  71. 71.
    Dixon AE, Clerisme-Beaty EM, Sugar EA, Cohen RI, Lang JE, Brown ED, et al. Effects of obstructive sleep apnea and gastroesophageal reflux disease on asthma control in obesity. J Asthma. 2011;48(7):707–13.PubMedCrossRefGoogle Scholar
  72. 72.
    Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Teodorescu M, Polomis DA, Teodorescu MC, Gangnon RE, Peterson AG, Consens FB, et al. Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults. J Asthma. 2012;49(6):620–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Sharma B, Feinsilver S, Owens RL, Malhotra A, McSharry D, Karbowitz S. Obstructive airway disease and obstructive sleep apnea: effect of pulmonary function. Lung. 2011;189(1):37–41.PubMedCrossRefGoogle Scholar
  75. 75.
    Julien JY, Martin JG, Ernst P, Olivenstein R, Hamid Q, Lemiere C, et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009;124(2):371–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Alharbi M, Almutairi A, Alotaibi D, Alotaibi A, Shaikh S, Bahammam AS. The prevalence of asthma in patients with obstructive sleep apnoea. Prim Care Respir J. 2009;18(4):328–30.PubMedCrossRefGoogle Scholar
  77. 77.
    Auckley D, Moallem M, Shaman Z, Mustafa M. Findings of a Berlin Questionnaire survey: comparison between patients seen in an asthma clinic versus internal medicine clinic. Sleep Med. 2008;9(5):494–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Bijaoui EL, Champagne V, Baconnier PF, Kimoff RJ, Bates JH. Mechanical properties of the lung and upper airways in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2002;165(8):1055–61.PubMedCrossRefGoogle Scholar
  79. 79.
    Mahadev S, Farah CS, King GG, Salome CM. Obesity, expiratory flow limitation and asthma symptoms. Pulm Pharmacol Ther. 2012.Google Scholar
  80. 80.
    Carpagnano GE, Spanevello A, Sabato R, Depalo A, Palladino GP, Bergantino L, et al. Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8. Transl Res. 2010;155(1):35–43.PubMedCrossRefGoogle Scholar
  81. 81.
    Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest. 2003;124(4):1386–92.PubMedCrossRefGoogle Scholar
  82. 82.
    Fletcher EC, Proctor M, Yu J, Zhang J, Guardiola JJ, Hornung C, et al. Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1688–96.PubMedCrossRefGoogle Scholar
  83. 83.
    Guilleminault C, Quera-Salva MA, Powell N, Riley R, Romaker A, Partinen M, et al. Nocturnal asthma: snoring, small pharynx and nasal CPAP. Eur Respir J. 1988;1(10):902–7.PubMedGoogle Scholar
  84. 84.
    Kerr P, Shoenut JP, Steens RD, Millar T, Micflikier AB, Kryger MH. Nasal continuous positive airway pressure. A new treatment for nocturnal gastroesophageal reflux? J Clin Gastroenterol. 1993;17(4):276–80.PubMedCrossRefGoogle Scholar
  85. 85.
    Ing AJ, Ngu MC, Breslin AB. Obstructive sleep apnea and gastroesophageal reflux. Am J Med. 2000;108(Suppl 4a):120S–5S.PubMedCrossRefGoogle Scholar
  86. 86.
    •• Xue Z, Yu Y, Gao H, Gunst SJ, Tepper RS. Chronic continuous positive airway pressure (CPAP) reduces airway reactivity in vivo in an allergen-induced rabbit model of asthma. J Appl Physiol. 2011;111(2):353–7. Paper showing that chronic continuous positive airway pressure reduces airway reactivity in an animal model of asthma.PubMedCrossRefGoogle Scholar
  87. 87.
    Desai LP, Wu Y, Tepper RS, Gunst SJ. Mechanical stimuli and IL-13 interact at integrin adhesion complexes to regulate expression of smooth muscle myosin heavy chain in airway smooth muscle tissue. Am J Physiol Lung Cell Mol Physiol. 2011;301(3):L275–84.PubMedCrossRefGoogle Scholar
  88. 88.
    Busk M, Busk N, Puntenney P, Hutchins J, Yu Z, Gunst SJ, et al. Use of continuous positive airway pressure reduces airway reactivity in adults with asthma. Eur Respir J. 2012;41(2):317–22.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Shyamala Pradeepan
    • 1
  • Garth Garrison
    • 2
  • Anne E. Dixon
    • 2
  1. 1.Department of Respiratory and Sleep MedicineJohn Hunter Hospital NewcastleNew LambtonAustralia
  2. 2.Department of MedicineUniversity of VermontBurlingtonUSA

Personalised recommendations